It is also called lipogranuloma because the retained lipid secretions are causing aggregation of certain cells, causing this granulomatous inflammation and it is sterile inflammation as there are no micro-organisms causing infection.

它也被称为脂肪肉芽肿，因为滞留的脂质分泌物引起某些细胞的聚集，导致这种肉芽肿炎症，而且它是无菌炎症，因为没有引起感染的微生物。

Prime Medicine, a biotech firm in Cambridge, Massachusetts, has already begun clinical trials of its drug PM359 for the treatment of chronic granulomatous disease—a life-threatening condition that affects the blood's ability to destroy infections.

马萨诸塞州剑桥市的生物科技公司 Prime Medicine 已开始对其药物 PM359 进行临床试验，该药物用于治疗慢性肉芽肿病——一种影响血液消灭感染能力的危及生命的疾病。